Frontier Medicines Company
Frontier Medicines is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery.
Investors
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical
Industry:
AI, Data Processing, Early Drug Development, United States
Headquarters:
San Francisco, California, United States
Founded Date:
2018-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
10
Total Funding:
244000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-07-19
Last Funding Type:
Series B
Register and Claim Ownership